Coombes RC, Tovey H, Kilburn L, et al. A phase III multicentre double blind randomised trial of celecoxib versus placebo in primary breast cancer patients (REACT – Randomised EuropeAn celecoxib trial). SABCS 2017, GS3-03.
GLP-1-receptoragonisten en risico op kanker bij volwassenen met obesitas
nov 2025 | Gynaecologische oncologie, Neuro-oncologie, Uro-oncologie